Absence of H- and K-ras oncogene mutations in sporadic medullary thyroid carcinoma

Citation
M. Bockhorn et al., Absence of H- and K-ras oncogene mutations in sporadic medullary thyroid carcinoma, EXP CL E D, 108(1), 2000, pp. 49-53
Citations number
27
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
ISSN journal
09477349 → ACNP
Volume
108
Issue
1
Year of publication
2000
Pages
49 - 53
Database
ISI
SICI code
0947-7349(2000)108:1<49:AOHAKO>2.0.ZU;2-N
Abstract
Medullary thyroid carcinoma (MTC) occurs sporadically (sMTC) or as part of the inherited cancer syndrome, multiple endocrine neoplasia type 2 (MEN 2). While the occurence of the MEN 2 syndrome is associated with mutations in the RET protooncogene, the reason for carcinogenesis in sMTC still remains unclear. Ras is a frequently mutated oncogene in a broad spectrum of human tumors an d has been found in about 50% of follicular, papillary or anaplastic thyroi d carcinomas. The purpose of this study was to determine, whether mutations in the ras oncogene could play a possible role in the carcinogenesis of sM TC. In this study we analyzed 15 sMTC for mutations in the hotspots codon 12, 1 3 and 61 of the H- and K-ras oncogene. We used the direct sequencing techni que. In none of the examined tumors we were able to detect a mutation in th e codon 12, 13 and 61 of the H-ras and K-ras oncogene. Based upon these results, we conclude that H- and K-ras do not play an impo rtant role in the carcinogenesis of sMTC.